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Large conductance calcium- and voltage-gated potassium (BK)
channels are important regulators of physiological homeostasis
and their function is potently modulated by protein kinase A (PKA)
phosphorylation. PKA regulates the channel through phosphory-
lation of residues within the intracellular C terminus of the pore-
forming -subunits. However, the molecular mechanism(s) by
which phosphorylation of the -subunit effects changes in channel
activity are unknown. Inhibition of BK channels by PKA depends on
phosphorylation of only a single -subunit in the channel tetramer
containing an alternatively spliced insert (STREX) suggesting that
phosphorylation results in major conformational rearrangements
of the C terminus. Here,we define themechanismof PKA inhibition
of BK channels and demonstrate that this regulation is conditional
on the palmitoylation status of the channel. We show that the
cytosolic C terminus of the STREX BK channel uniquely interacts
with the plasma membrane via palmitoylation of evolutionarily
conserved cysteine residues in the STREX insert. PKA phosphory-
lation of the serine residue immediately upstreamof the conserved
palmitoylated cysteine residues within STREX dissociates the C
terminus from the plasma membrane, inhibiting STREX channel
activity. Abolition of STREX palmitoylation by site-directed mu-
tagenesis or pharmacological inhibition of palmitoyl transferases
prevents PKA-mediated inhibition of BK channels. Thus, palmitoyl-
ation gates BK channel regulation by PKA phosphorylation. Pal-
mitoylation and phosphorylation are both dynamically regulated;
thus, cross-talk between these 2 major posttranslational signaling
cascades provides a mechanism for conditional regulation of BK
channels. Interplay of these distinct signaling cascades has impor-
tant implications for the dynamic regulation of BK channels and
physiological homeostasis.
KCNMA1  acylation  protein kinase A  maxi-K
Large conductance calcium- and voltage-gated potassium (BK)channels are potently regulated by protein phosphorylation (1)
and are important determinants of neuronal, cardiovascular, en-
docrine, and epithelial function where channel dysfunction may
lead to major disorders such as hypertension (2, 3), ataxia (4),
epilepsy (5, 6), and incontinence (7). BK channels are potently
regulated by phosphorylation, and several putative phosphorylation
motifs on the pore-forming -subunit have been identified (8–12).
However, as for other potassium channels, the molecular basis
through which phosphorylation of the -subunit effects changes in
BK channel activity is essentially unknown.
BK channel pore-forming -subunits are encoded by a single
gene, KCNMA1 (13), and native BK channels show functional
heterogeneity in their response to protein kinase A (PKA)-
mediated phosphorylation. This diversity results, in large part, from
the extensive alternative pre-mRNA splicing of the pore-forming
-subunits (10, 12). Previous studies have demonstrated that PKA
phosphorylation of a conserved C-terminal phosphorylation motif.
RQPS899 results in BK channel activation (9, 10, 14). Inclusion of
the stress regulated exon (STREX) (15) in the intracellular C
terminus generates an additional PKA consensus motif (serine
residue 3 of the STREX insert, S3) that results in channel inhibition
by PKA (10, 14). PKA inhibition of STREX follows a single-subunit
rule, whereby only 1 -subunit within the BK channel tetramer is
required to be phosphorylated by PKA on S3 for inhibition to be
conferred (14). Thus, phosphorylation of a single STREX -sub-
unit probably induces major conformational rearrangements in the
BK channel C terminus to mediate channel inhibition.
The STREX insert is cysteine-rich (6 of 58 aa) that, when
included into the BK channel -subunit C terminus, generates a
cysteine-rich domain (CRD) in the intracellular linker between the
2 regulator of conductance (RCK) domains (Fig. 1A). In many
proteins, including other voltage- and ligand-gated ion channels
(16–21), cysteine residues are common targets for protein palmi-
toylation, the covalent attachment of a palmitate lipid to a cysteine
residue via a thioester bond. Palmitoylation can exert diverse effects
on protein function including allowing cytosolic protein domains to
anchor to the plasma membrane (22–24).
We thus hypothesized that palmitoylation of the STREX insert
might target the C-terminal domain of the BK channel to the
plasma membrane independently of the N-terminal transmem-
brane domains. Furthermore, this suggested a mechanism by which
phosphorylation of a single STREX subunit could result in channel
inhibition—through regulation of STREX domain interaction with
the plasma membrane. To test these hypotheses, we exploited an
integrated imaging, electrophysiological, and biochemical ap-
proach. We demonstrate that PKA-inhibition of BK channels
results from dissociation of the STREX domain from the plasma
membrane. Importantly, palmitoylation of STREX provides a
conditional gate for regulation of BK channel activity by PKA
phosphorylation.
Results and Discussion
STREX Insert Is a Membrane-Anchoring Domain of the Cytosolic C
Terminus of the BK Channel. To address whether the cysteine-rich
STREX domain is a membrane-anchoring module we developed
an imaging assay to screen the ability of the STREX insert, and its
cognate cysteine residues, to anchor the STREX C terminus to the
plasmamembrane in the absence of theN-terminal transmembrane
domains of the -subunit. We generated fluorescentGFP fusion
constructs of the entire BK channel C terminus (Fig. 1B) as well as
constructs that encompass the CRD as fluorescent fusions with
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flankingmCer- and/orYFP fusion proteins tomimic the STREX
linker region between the RCK domains (Fig. 1C).
Expression of STREX C-terminal (Fig. 1B) or CRD constructs
(Fig. 1C) resulted in robust plasma membrane expression of the
fusion proteins in HEK293 cells in the absence of full-length BK
channels or transmembrane segments. Identical results were also
obtained in cells that endogenously express STREX variant chan-
nels including murine anterior pituitary corticotrope (AtT20) cells,
rat pheochromocytoma PC12 cells, and human insulinoma INS-1
cells (data not shown). In contrast, in all these systems, expression
of C-terminal, or CRD, fusion proteins that lack the STREX insert
(ZERO constructs), but that are otherwise identical to the STREX
constructs, did not localize to the membrane (Fig. 1 B–D). Coex-
pression of an HA-tagged STREX C terminus (STREX*) res-
cued the ZERO C-terminal GFP fusion protein localization to
the plasma membrane (Fig. 1B Lower Right). Thus, a STREX
subunit within a heteromeric assembly is sufficient to localize the
BK channel C terminus at the plasma membrane. These data
demonstrate that STREX acts as a membrane-targeting/anchoring
domain and that the key plasmamembrane localizationmotifsmust
reside within the CRD domain.
To determine whether the cysteine residues within the CRD
control membrane localization of the STREX C terminus, we
mutated cysteine residues to alanine in both the C-terminal and
CRDSTREX constructs.Mutation of residueC13 to alanine alone
almost abolished membrane targeting in both fusion proteins (Fig.
1D), and mutation of its upstream vicinal cysteine residue (C12)
significantly reduced membrane localization. The double-mutant
C12:13A abolished membrane targeting of both fusion proteins
(Fig. 1 B–D). In contrast, mutation of any of the other cysteine
residues within the CRD had no significant effect on membrane
localization (Fig. 1 B–D).
Palmitoylation of STREX Is Required for Membrane Targeting of the
C Terminus. Using the CSS-palm palmitoylation algorithm (25), we
predicted that 4 of the 6 cysteine residues within the STREX insert
might be palmitoylated (Fig. 1A and Table S1), with cysteine
residues 12 and 13 in STREX having the highest CSS-palm scores.
Because mutation of C12 and C13 abolished membrane targeting
of the STREXC terminus, this data suggests that palmitoylation of
these residues controls STREX C terminus association with the
plasma membrane. These STREX cysteine residues are highly
evolutionarily conserved in vertebrates (Fig. 1A).
To directly address whether BK channels are in fact palmitoy-
lated in vivo, we assayed 3H-palmitate incorporation into full-length
channels, and the CRD construct, expressed inHEK293 cells. Both
full-length ZERO and STREX channels were robustly palmitoy-
lated in HEK293 cells by endogenous palmitoyl transferases (Fig.
Fig. 1. STREX targets BK channel C termi-
nus to the plasma membrane. (A) Schematic
illustrating the topology of the BK channel
pore forming -subunit. The STREX insert is
located in the linker between the 2 predicted
regulator of K conductance (RCK) domains
in the intracellular C terminus. Inclusion of
STREX generates a CRD encompassing the
heme-binding domain (hbd) and STREX. Se-
quence alignment indicates evolutionarily
conserved cysteine residues in the STREX in-
sert predicted to be palmitoylated by the
CSS-palm algorithm (shaded) and the PKA
phosphorylation site serine S3 (indicated by
the asterisk). Cysteine residues are numbered
in the CRD as follows: STREX residues num-
bered from the first STREX residue (K) and
upstream cysteines labeled by letters. (BandC)
Schematic of C-terminal GFP fusion (B) and
CRD domain (C) fused between CFP and YFP
constructs and representative single confocal
section images of STREX, STREX cysteine mu-
tants C12:13A and C23:25A, and the ZERO
variant (STREX insert excluded) expression in
HEK293 cells. In B Lower Right, the C-
terminal ZERO–GFP fusion construct was co-
transfected with a modified C-terminal
STREX construct (STREX*) in which theGFP
tag of STREX was replaced with an HA
epitope. (Scale bars: 5 m.) (D) Summary bar
chart of the respective C-terminal (f) or CRD
() construct localization at the plasma
membrane expressed as a percentage of the
respective STREX expression. Data are
means  SEM, N  12, n  350 for each
construct.**,P0.01 compared with respec-
tive STREX construct (ANOVA with Student–
Neuman–Keuls post hoc test).







2A). Importantly, the STREX CRD construct is robustly palmi-
toylated, and 3H-palmitate incorporation was essentially abolished
in the C12:13Amutant, suggesting that these residues are themajor
sites of palmitoylation within the CRD (Fig. 2A). As an alternative
biochemical approach to confirm endogenous palmitoylation of
STREX channels on cysteine residues, we also exploited a cysteine-
accessibility assay (26) after treatment of STREX channels with 1
M neutral hydroxylamine (ha). Ha cleaves the thioester bond
between endogenous palmitate and cysteine residues, allowing
previously palmitoylated cysteine residues to become accessible to
the sulfydryl-specific reagent biotin-BMCC (Fig. 2B). Functionally,
pretreatment of HEK293 cells with the palmitoyl transferase in-
hibitor 2-bromopalmitate [2-BP (27)] also abolished membrane
targeting of the STREXC terminus andCRD fusion proteins in the
imaging assays (Fig. 2C) as for the palmitoylation-deficient
C12:13A mutant. As a control for general effects on posttransla-
tional lipid modification, the myristoylation inhibitor 2-hydroxy-
myristate had no significant effect on C-terminal or CRD targeting
in these assays (Fig. 2C), and the vehicle (0.1% DMSO) was also
without effect (data not shown). Thus, although the 3H-palmitate-
incorporation assays and CSS-palm predictions reveal that cysteine
residues common to both the full-length ZERO and STREX
channels may be palmitoylated, only the C12 and C13 residues are
functionally important for membrane localization of the STREXC
terminus at the plasma membrane. Taken together, these data
support the hypothesis that the key determinant of STREXdomain
association with the plasma membrane results from palmitoylation
of the STREX insert.
PKA Phosphorylation Dissociates the STREX C Terminus from the
PlasmaMembrane. PKA inhibition of STREXchannels results from
phosphorylation of serine residue 3 within the STREX insert (10,
14) that is just upstream of the site of palmitoylation (C12:13). We
reasoned that phosphorylation of S3, which would introduce a
negative charge into an otherwise basic region immediately up-
stream of C12:13, might result in destabilization of the STREX
domain with the plasmamembrane leading to significant structural
rearrangements and thus channel inhibition.We took 3 approaches
to test this idea. First, we generated the STREX PKA phospho-
mimetic S3E by mutating STREX S3 to glutamic acid. The S3E
mutation abolished STREX C-terminal or CRD construct local-
ization at the plasma membrane (Fig. 3 A and C). The serine-to-
aspartate mutation (S3D, data not shown) also significantly re-
ducedmembrane expression, suggesting that both the S3E and S3D
mutants largely mimic PKA phosphorylation of S3. In contrast,
phosphomimetic mutation of S899 in the downstream C terminus,
which is the major site for PKA activation (9, 10, 14), had no
significant effect on STREX C terminus association with the
plasmamembrane (Fig. 3A andC). However, the phosphomimetic
mutations do not allow us to distinguish between a plasma mem-
brane trafficking defect and a reduced association of theC-terminal
domains once at the plasma membrane. Thus, in the second series
of experiments, we acutely treated HEK293 cells, expressing the
wild-type STREX C-terminal or CRD constructs at the plasma
membrane, with the membrane-permeable cAMP analogue
8-CPT-cAMP to establish whether constructs resident at the
plasma membrane could be dissociated by PKA phosphorylation.
Pretreatment of cells with 0.1 mM 8CPT-cAMP, in the presence or
absence of 10 nM okadaic acid, significantly reduced membrane
association of the STREX constructs (Fig. 3B). Importantly,
cAMP-induced dissociationwas abolished by pretreatment with the
cell-permeable PKA inhibitor H89. In contrast, activation of pro-
tein kinase G (PKG) or C (PKC) had no effect on STREX
localization at the plasmamembrane (Fig. 3D). In addition, neither
acute (3% O2), hypoxia (Fig. 3D), which also regulates BK
channels through the STREX insert (28), nor ionomycin-induced
calcium elevation or KCl-induced depolarization (Fig. S1) had any
significant effect on the plasma membrane localization of STREX.
These data support a model in which PKA phosphorylation of
STREX results in dissociation of the STREX domain from the
plasma membrane.
Palmitoylation Gates BK Channel Regulation by PKA. If this model
were correct, we would predict that PKA inhibition of STREX BK
channels would be lost in channels that are not palmitoylated. To
test this hypothesis, we examined the regulation of wild-type
STREX channels and the STREX palmitoylation-deficient mutant
C12:13A in electrophysiological assays. STREX channels are ro-
bustly inhibited by endogenous PKA closely associated with the
channel upon exposure of the intracellular face of the patch to
cAMP (Fig. 3 E and G). The effect of cAMP is abolished by the
PKA inhibitor PKI5-24, but not by inhibitors of PKG, PKC, or
CaMKII (Fig. S2) and is mimicked by application of exogenous
catalytic subunit of PKA (PKAc) (Fig. 3G). Although full-length
C12:13A channels are robustly expressed at the plasma membrane
(Fig. 3 F and H), suggesting the full-length C12:13A mutant is not
itself trafficking deficient, cAMP or PKAc fail to inhibit this
mutant. Furthermore, the inhibitory effect of cAMP on wild-type
STREX channels was abolished in cells pretreated overnight with
the inhibitor of palmitoylation, 2-BP (Fig. 3G). The C12:13A
mutation, and inhibition of STREX channel palmitoylation by
2-BP, which both dissociate the C terminus from the plasma
membrane (Fig. 2C), resulted in a right shift in the half-maximal
voltage for activation (Fig. S3a). Reduced basal activity per se is not
responsible for the loss of cAMP-mediated inhibition because
cAMP potently inhibited STREX channels recorded under con-
ditions to match the shift in V0.5 resulting from the C12:13A
Fig. 2. Palmitoylation of STREX required for membrane localization. (A)
Representative fluorographs (Upper) and Western blots (Lower) of full-length
STREX-HA and ZERO-HA channels (Left) and the wild-type STREX and mutant
C12:13A CRD-YFP constructs (Right) expressed in HEK293 cells. Constructs
were labeled with 3H-palmitate for 4 h and the respective constructs immu-
noprecipitated (IP) by using -HA or -GFP magnetic microbeads respectively
and detected by fluorography. (B) Representative blots from a cysteine-
accessibility assay after IP and treatment of STREX channels with 1 M neutral
hydroxylamine to cleave endogenous palmitate thioester bonds to cysteine
residues. Accessible cysteines were probed by using biotin-BMCC (Upper) with
total protein probed by -HA (Lower). (C) Summary imaging data of STREX
and C12:13A C terminus (f) or CRD () as in Fig. 1 B–D and the effect of 24-h
pretreatment of cells with the palmitoyltransferase inhibitor 2-bromopalmi-
tate (2-BP, 100 M) or the myristoylation inhibitor 2-hydroxymyristate (2-HM,
0.1–1 mM). Data are means  SEM, N  14, n  950 for each construct/
treatment. **, P  0.01 compared with respective STREX construct (ANOVA
with Student–Neuman–Keuls post hoc test).
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mutation (e.g., at 20 mV in 0.1 M free calcium, inhibition was
67  7% of control, n  12).
Palmitoylation appears to specifically gate PKA-mediated inhi-
bition of STREX channels because the palmitoylation status of
STREX does not alter its intrinsic hypoxia sensitivity (28) (Fig. 3G
andH) or the regulation by PKG-dependent phosphorylation (Fig.
S3b). Moreover, inhibition of palmitoylation by 2-BP does not
modulate PKA-dependent activation of the ZERO splice variant
(Fig. S3c) that depends on phosphorylation of a PKA consensus
motif (S899) outwith the STREX insert.
Furthermore, the model proposed for palmitoylation-dependent
gating of PKA inhibition of STREX would be expected to adhere
to a ‘‘same-subunit’’ rule based on the previous demonstration that
only a single subunit of STREX needs to be phosphorylated at S3
for channel inhibition (14). The same-subunit model would predict
that PKA inhibition, as a result of phosphorylation of STREXat S3,
would occur only if the same subunit is also palmitoylated atC12:13.
By using a TEA-pore mutation strategy (Y334V) to determine
channel subunit stoichiometry (14), cotransfection of subunits that
could be palmitoylated but not phosphorylated (constructs with
S3Amutation) togetherwith subunits that could be phosphorylated
but not palmitoylated (constructs with C12:13Amutation) revealed
that cAMP was unable to inhibit channel activity (mean change in
activity was 4  10%, n  12). In contrast, introduction of even a
single subunit that could be both phosphorylated and palmitoylated
(i.e., a wild-type STREX subunit) with subunits that could be
palmitoylated but not phosphorylated (S3A constructs) resulted in
robust channel inhibition by cAMP (inhibition was 71  6%, n 
8). These data demonstrate that palmitoylation of the same subunit
in which the channel is phosphorylated is required for PKA-
mediated inhibition.
To examinewhether palmitoylation gates native STREXchannel
regulation, we examined the regulation of BK channels in mouse
anterior pituitary corticotrope (AtT20) cells. STREX variant chan-
nels are robustly expressed in this system and are potently inhibited
by cAMP-dependent protein phosphorylation (29). cAMPpotently
inhibited the outward paxilline-sensitive (BK) current in these cells
(Fig. 4). Pretreatment of AtT20 cells with 2-BP abolished cAMP-
mediated inhibition of the BK current in the whole-cell configura-
tion (Fig. 4). Similar data were obtained in perforated-patch
recordings: 8-CPT-cAMP-mediated inhibition of the paxilline-
sensitive current in 2-BP-treated cells was only 7  8% (n  4) of
that observed by 8-CPT-cAMP in vehicle-treated controls.
BK channels are remarkable in the range of physiological pro-
cesses they control, their functional heterogeneity as a result of
alternative splicing of the single gene encoding the pore-forming
-subunits, and their extensive regulation by reversible protein
phosphorylation. Our data reveal the molecular basis for PKA-
mediated inhibition of BK channels through the regulation of
STREX domain interaction with the plasma membrane. Palmi-
toylation of the STREX domain uniquely allows the large intra-
cellular C terminus of the STREX splice variant to associate with
the plasma membrane and, importantly, gates the regulation of
STREXchannels by PKA.Critically, this regulation depends on the
site of palmitoylation being adjacent to the site of phosphorylation
in the same subunit polypeptide. Importantly, STREX channel
activation by PKG-mediated phosphorylation was not affected by
palmitoylation status. Furthermore, PKA-activation of ZERO
Fig. 3. PKA phosphorylation of STREX dissociates STREX from plasma membrane. (A) Representative single confocal sections from HEK293 cells expressing
wild-type STREX C-terminal constructs and the corresponding STREX and C-terminal PKA phosphorylation site phosphomimetic constructs S3E and S899E. (Scale
bars: 5 m.) (B) Effect of cell-permeable cAMP analogue 8-CPT-cAMP (0.1 mM, 10–30 min) on STREX C terminus (f) or CRD () membrane localization in the
presence or absence of 10 nM okadaic acid or the PKA inhibitor H89 (1 M). (C) Summary of S3E and S899E construct expression at the plasma membrane (na,
S899 site not present in CRD construct). (D) Effect of acute hypoxia (3% O2), PKG activation with the cell-permeable cGMP analogue 8-CPT-cGMP (0.1 mM in
the presence of 10 nM okadaic acid) or PKC activation with the phorbol ester PMA (100 nM in the presence of 10 nM okadaic acid) on construct localization at
the plasma membrane. Data are means  SEM, N  4, n  350. (E and F) Representative single-channel traces and diary plots of single-channel mean open
probability (Po) from isolated inside-out patches of HEK293 cells expressing full-length STREX (E) or C12:13A (F) channels before and 10 min after exposure to
cAMP. Single channels were assayed in physiological Kgradients exposed to 0.2M free calcium and 2 mM Mg-ATP. (G andH) Inhibition of STREX (G) or C12:13A
(H) channel Po by cAMP (0.1–1.0 mM) in the presence or absence of the PKA inhibitor PKI5-24 (0.45 M) or 24-h cell pretreatment with 100 M 2-BP; application
of catalytic subunit of PKAc (300 nM) or exposure to acute hypoxia (3%O2). Data are means SEM, n 5–14 for each treatment. **, P 0.01 compared with
respective control (ANOVA with Student–Neuman–Keuls post hoc test).







channels was not affected by inhibitors of protein palmitoylation.
PKA and PKG activation of BK channels is independent of the
STREX insert and is thought to be mediated by consensus phos-
phorylation sites in the more distal C terminus (8–10, 12, 14).
Importantly, these sites are not juxtaposed to predicted sites of
palmitoylation, further supporting ourmodel inwhich the cross-talk
between PKA inhibition and palmitoylation status of STREX
depends on both PKA phosphorylation and palmitoylation being in
close proximity on the same subunit in the tetramer, thus obeying
the single-subunit rule of PKA inhibition (14).
To what extent may such cross-talk between these major, dy-
namically regulated, lipid and phosphorylation signaling pathways
occur in other ion channels? Protein phosphorylation is a funda-
mental mechanism to control ion channel function, and increasing
evidence suggests that multiple ion channels are also regulated by
palmitoylation (16–21). We would predict that phosphorylation–
palmitoylation cross-talk is likely to occur when sites of palmitoyl-
ation are flanked by sites of serine/threonine phosphorylation. In
support of this, our pilot sequence analysis reveals (M.J.S. and
I.C.M.R., unpublished work) that in several ion channels reported
or predicted to be palmitoylated, the sites of palmitoylation are
frequently flanked by putative sites for serine/threonine phosphor-
ylation (M.J.S. and I.C.M.R., unpublished work). For example, in
ligand-gated GluR6 receptors, the identified sites of palmitoylation
are flanked by potential PKC phosphorylation sites, and it has been
reported that palmitoylation modifies PKC-mediated phosphory-
lation of GluR6 receptors (20). Thus, cross-talk between these
major posttranslational regulatory pathways, at the level of a single
ion channel polypeptide as reported here for BK channels, is likely
to be of much broader significance to conditionally regulate a
variety of other ion channels.
Although our data reveal that native BK channels are regulated
by this palmitoylation–PKA phosphorylation cross-talk, significant
challenges for the future will be to examine: (i) physiologically
relevant signaling pathways that dynamically regulate BK channel
palmitoylation and (ii) the functional relevance of this cross-talk on
cellular and systems physiology. For example, PKA inhibition of BK
channels is important for the control of stress hormone secretion in
AtT20 pituitary corticotrope cells, and inhibitors of secretion can
prevent PKA-mediated regulation of BK channels in this system
(29). However, because palmitoylation also controls multiple levels
of hormone secretion, including components of the secretory
apparatus per se, a major goal for the future will be to develop tools
to dissect the relative importance of palmitoylation cross-talk at the
level of BK channels compared with other palmitoylation-
dependent pathways in native systems.
Palmitoylation, like protein phosphorylation, is a dynamically
regulated mechanism (22, 23, 30). Thus, elucidation of signaling
pathways that control ion channel palmitoylation, together with
examination of cross-talk with phosphorylation signaling pathways
as reported here, will provide important insights into the role of
these distinct signaling pathways in the control of BK, and other ion
channel function and their role in physiological homeostasis.
Materials and Methods
Channel Constructs. The generation of full-length murine ZERO and STREX
channel epitope-tagged as well as TEA-pore mutant (Y334V) constructs have
been described (14, 31). C-terminal GFP constructs, the respective CRD con-
structs, and site-directed mutants were generated and sequence-verified as
described in SI Methods.
Cell Lines, Transfection, and Treatments. HEK293 cells and mouse anterior pituitary
corticotrope AtT20 D16:16. HEK293 cells and mouse anterior pituitary corticotrope
AtT20 D16:16 (passage 18–32) were subcultured essentially as described (10, 14,
29). Cells were transiently transfected by using Lipofectamine 2000 (Invitrogen)
or Fugene-HD.
Cell treatments:The palmitoylation inhibitor 2-bromopalmitate (2-BP; Sigma) was
madeasafresh100mMstock inDMSOandappliedatafinalconcentrationof100
M overnight. For the myristoylation inhibitor 2-hydroxmyristate (2-HM; Sigma)
fresh stock solutions were made either complexed to BSA, or dissolved in DMSO
as for 2-BP, and applied at 0.1–1 mM final concentration in each well. For acute
imaging assays, cells were incubated for 1 h in DMEM containing 15 mM Hepes
and 0.25% BSA (pH 7.4) at 37 °C before incubation for 10–30 min with fresh
medium containing the respective drug treatment before rapid fixing. For acute
hypoxia,mediumwascontinuouslybubbledwithnitrogengas (O2 levelare3%,
equivalent to25 mmHg) and during fixation.
Imaging Assays. Cells were fixed with 4% paraformaldehyde, mounted in
Mowiol, and analyzed under epifluorescence by using an inverted Nikon Eclipse
2000 microscope with a 100 oil objective lens. Confocal images were acquired
on a Zeiss LSM510 laser scanning microscope with a 63 oil Plan Apochromat
(N.A. 1.4) objective lens, in multitracking mode to minimize channel cross-talk.
Membrane expression was quantified by using the LSM browser or Volocity
software as described in SI Methods. Data are shown as mean  SEM for N
independent experiments where n  minimum total number of cells analyzed
across experiments for each construct.
Palmitoylation Prediction and Palmitoylation Assays. CSS-palm prediction. We
exploited the published CSS-palm palmitoylation algorithm (25) to predict cys-
teine residues within the entire coding sequence of the murine STREX BK channel
-subunit as well as the STREX insert alone (see Table S1). Sequences were
analyzed with both the published CSS-palm v1.0 algorithm as well as the recently
refined CSS-palm v2.0 web interface. In both cases palmitoylation prediction was
initially set to the highest cutoff in both algorithms.
3H palmitic acid incorporation. HEK293 cells were transiently transfected in 6-well
cluster dishes (3  106 cells per well) with full-length STREX-HA, ZERO-HA
channels or the STREX CRD-YFP and CRD-C12:13A-YFP constructs, respectively.
Forty-eight hours after transfection, cells were washed, and 1 mL of fresh DMEM
containing 10 mg/ml fatty acid-free BSA was added for 30 min at 37 °C. Cells were
incubated in DMEM/BSA containing 0.8 mCi/ml 3H-palmitic acid for 4 h at 37 °C,
and then the medium containing the free label was removed. Cells were lysed in
150 mM NaCl, 50 mM Tris-Cl, 1% Triton X-100 (pH 8.0), and channel fusion
proteins were captured by using magnetic microbeads coupled to HA/GFP anti-
body (MACS epitope tag isolation kits, Miltenyi Biotec). After washing columns
with150mMNaCl,1%NonidetP-40,0.5%deoxycholate,0.1%SDS,50mMTris-Cl
(pH 8.0), followed by washes with 50 mM Tris-Cl (pH 7.5) captured proteins were
eluted in SDS/PAGE sample buffer [50 mM Tris-Cl (pH 6.8), 5 mM DTT, 1% SDS, 1
mM EDTA, 0.005% bromophenol blue, 10% glycerol] prewarmed to 95 °C. The
recovered samples were separated by SDS/PAGE, transferred to nitrocellulose
membranes, and probed with either a monoclonal GFP antibody (1:3,000; Clon-
tech) or polyclonal HA antibody (1:1,000; Zymed). A duplicate membrane was
dried, sprayed with En3hance fluorographic spray (PerkinElmer–Cetus) and ex-
posed to light-sensitive film at 80 °C by using a Kodak Biomax transcreen LE
(Amersham).
Cysteine-accessibility assays. Cysteine-accessibility assays were performed essen-
tially as described by Drisdel (26). Cells were lysed at 4 °C in buffer containing 150
Fig. 4. Palmitoylation gates PKA inhibition of BK channels in native cells. (A
and B) Representative whole-cell outward current traces from mouse anterior
pituitary corticotrope (AtT20) cells pretreated with vehicle (0.01% DMSO) (A)
or 2-BP (24 h, 100 M) (B) before (control) or 10 min after intracellular dialysis
with 0.1 mM cAMP or extracellular application of a 1M concentration of the
BK channel inhibitor paxilline. Cells were voltage clamped at 50 mV in
physiological potassium gradients and traces shown recorded during voltage
steps to 40 mV for 100 ms. (C) Mean current density (pA/pF) of paxilline-
sensitive current from vehicle- and 2-BP-treated AtT20 cells determined 90 ms
into the pulse at 40 mV. (D) Percentage inhibition of paxilline-sensitive
current (Ipax) by cAMP in vehicle- and 2-BP-treated cells. Data are means 
SEM, n  9 for each treatment. **, P  0.01 compared with cAMP inhibition
in vehicle control (ANOVA with Student–Neuman–Keuls post hoc test).
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mM NaCl, 50 mM Hepes (pH 7.5), 1.5 mM MgCl2, 1 mM EDTA, and 1% Triton-X-
100 containing 25–50 mM N-ethylmaleimide (NEM) to block reactive cysteines.
Cell lysates were spun, supernatants precleared with protein-G beads (Sigma),
and incubated overnight at 4 °C with mouse monoclonal -HA antibody. Immu-
nopurified channels were rapidly washed 3 times in lysis buffer without NEM and
treated with 1 M ha (ha) (pH 7.4) for 1 h or 1 M TrisHCl (pH 7.4) as a control
(ha). After washing, beads were exposed to the sulfydryl-specific biotinylating
reagent biotin-BMCC (10 M; Pierce) for 2 h at room temperature. Labeled
proteins were run on SDS/PAGE, transferred to PVDF membrane, and probed
with streptavidin-conjugated horseradish peroxidase (HRP) and detected by ECL.
Electrophysiological Assays.HEK293 cells. Single-channel current recordings were
performedinthe inside-outconfigurationof thepatch-clamptechnique,at room
temperature (20–24 °C). The pipette solution (extracellular) contained 140 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 2 mM MgCl2, 20 mM glucose, 10 mM Hepes (pH 7.4).
The bath solution (intracellular) contained 140 mM KCl, 5 mM NaCl, 2 mM MgCl2,
1 mM BAPTA, 30 mM glucose, 10 mM Hepes, 1 mM ATP (pH 7.3) with free calcium
[Ca2]i buffered to 0.2 M, unless indicated otherwise. Channel activity was
determined during 60-s depolarizations to40 mV. Data acquisition and voltage
protocolswerecontrolledbyanAxopatch200BamplifierandpCLAMP9software
(Axon Instruments). All recordings were sampled at 10 kHz and filtered at 2 kHz.
Channel activity was allowed to stabilize for at least 10 min after patch excision
before addition of drugs. Catalytic subunit of PKAc was from Promega. The
8-CPT-cGMP, 8-CPT-cAMP, KT5823, chelerythrine chloride, KN-62, and PKI5-24
were from Calbiochem.
Single-channel open probability (Po) was derived either from single-channel
analysis using pSTAT (Axon Instruments) or WINEDR (Version 2.3.9, J. Dempster,
University of Strathclyde, U.K.). To determine the mean percentage change in
channel activity after a treatment, mean Po or N*Po was measured immediately
before and 10 min after the respective drug application. The effect of cAMP
and/or PKAc on channel activity was typically maximal by5 min and remained
stable over the next 10–30 min after application to inside-out patches. The effect
of PKA-mediated phosphorylation was abolished in the absence of Mg-ATP and
could be reversed upon application of the catalytic subunit of protein phospha-
tase 2A (data not shown).
Mouse anterior pituitary corticotrope (AtT20) cells. Whole-cell currents were
recording in the conventional whole-cell recording mode of the patch-clamp
technique. The bath solution (extracellular) contained 140 mM NaCl, 5 mM KCl,
2 mM MgCl2, 1 mM CaCl2, 10 mM Hepes, and 20 mM glucose (pH 7.4) with or
without 0.002 tetrodotoxin. The patch pipette (intracellular) contained 140 mM
KCl, 2 mM MgCl2, 10 mM Hepes, 30 mM glucose, 1 mM BAPTA, and 1 mM ATP (pH
7.4) with intracellular free calcium ([Ca2]i) buffered to 200 nM. Perforated-patch
recordingswereconductedbyusingamphotericin inthepatchpipette.Cellswere
voltage clamped at50 mV and depolarized to the respective potentials for 100
ms with leak subtraction applied by using a P/4 protocol and series resistance
compensation of 50%. Steady-state outward current was determined 90 ms
into the pulse and was stable for30 min under these conditions.
Statistical Analysis. All data are presented as means SEM withN number of
independentexperimentsandnnumberof individualcellsanalyzedin imaging
assays.DatawereanalyzedbyANOVAwithposthocStudent–Neuman–Keuls test
with significance set at P 0.01.
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